Oriol Guitart-Pla

The paper introduces a protocol to integrate diverse bioactivity data into the Chemical Checker compound universe, enabling the generation of novel bioactivity signatures for small molecules.

The paper introduces deep neural networks to infer bioactivity signatures for uncharacterized compounds, improving activity prediction across various biological endpoints.

The paper introduces Chemical Checker, a resource that integrates bioactivity data on 800,000 small molecules and demonstrates its use in drug discovery and disease modeling.